ACADIAN ASSET MANAGEMENT LLC - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 30 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q4 2021$120,000
+76.5%
55,813
+172.0%
0.00%
Q3 2021$68,000
-19.0%
20,516
-35.5%
0.00%
Q2 2021$84,000
+425.0%
31,793
+296.0%
0.00%
Q3 2020$16,000
+77.8%
8,029
+175.6%
0.00%
Q2 2020$9,000
+12.5%
2,9130.0%0.00%
Q1 2020$8,000
-42.9%
2,9130.0%0.00%
Q4 2019$14,000
-17.6%
2,9130.0%0.00%
Q3 2019$17,000
-10.5%
2,9130.0%0.00%
Q2 2019$19,0002,9130.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q3 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,349,953$8,046,0002.52%
Novo Holdings A/S 2,181,843$13,004,0002.23%
Sofinnova Investments, Inc. 1,180,178$7,034,0000.64%
TPG Group Holdings (SBS) Advisors, Inc. 2,041,496$12,168,0000.09%
Eventide Asset Management 392,513$2,288,0000.08%
Blackstone Inc. 1,623,405$9,675,0000.06%
Granahan Investment Management 141,012$840,0000.05%
Janney Montgomery Scott LLC 46,861$279,0000.00%
BANK OF MONTREAL /CAN/ 5,921$35,0000.00%
BlackRock Inc. 15,755$94,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders